Ernexia Therapeutics Files 8-K with Amendments and Exhibits
Ticker: ERNAW · Form: 8-K · Filed: Jun 12, 2025 · CIK: 748592
| Field | Detail |
|---|---|
| Company | Ernexa Therapeutics Inc. (ERNAW) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
Ernexia Therapeutics filed an 8-K on 6/12/25 for corporate updates and financials.
AI Summary
Ernexia Therapeutics Inc. filed an 8-K on June 12, 2025, reporting amendments to its Articles of Incorporation or Bylaws and filing financial statements and exhibits. The company, formerly known as Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., and NTN BUZZTIME INC, is incorporated in Delaware and has its principal executive offices in Cambridge, MA.
Why It Matters
This filing indicates corporate governance updates and the submission of financial information, which are crucial for investors to understand the company's current operational and legal standing.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain significant negative news or events.
Key Players & Entities
- Ernexia Therapeutics Inc. (company) — Registrant
- Eterna Therapeutics Inc. (company) — Former company name
- Brooklyn ImmunoTherapeutics, Inc. (company) — Former company name
- NTN BUZZTIME INC (company) — Former company name
- June 12, 2025 (date) — Date of report
FAQ
What specific amendments were made to Ernexia Therapeutics Inc.'s Articles of Incorporation or Bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the provided text excerpt. The full filing would need to be reviewed for specifics.
What financial statements and exhibits are being filed with this 8-K?
The filing states that Financial Statements and Exhibits are being filed, but the specific list or content of these documents is not detailed in the provided excerpt.
When was Ernexia Therapeutics Inc. previously known as Eterna Therapeutics Inc.?
The date of the name change from Eterna Therapeutics Inc. to Ernexia Therapeutics Inc. was October 17, 2022.
What is Ernexia Therapeutics Inc.'s fiscal year end?
Ernexia Therapeutics Inc.'s fiscal year ends on December 31st.
What is the business address of Ernexia Therapeutics Inc.?
The business address is 1035 Cambridge Street, Suite 18A, Cambridge, MA 02141.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Ernexa Therapeutics Inc. (ERNAW).